Biopharma Analyst, Event Driven Hedge Fund (London) – Updated
Our client, a large global hedge fund, would like to add a biopharma analyst to focus on investments in equity and credit events including bonds, loans, equity activism, merger arb and private equity. The role involves taking a deep dive, providing modeling and valuation of corporate names, to develop an investment view of biotech and pharmaceutical companies. The Analyst will focus on catalyst-driven and special situations. The fund avoids binary events based on drug trials and approvals or quarterly earnings. The analyst reports directly to a portfolio manager and a top performer will have an opportunity to develop into a PM role.
The ideal candidates should come from life sciences investment banking or a buyside role in either private equity or public investing. The team has deep biotech and pharma expertise, but the role does not require an advanced science or medical degree. The Analyst must understand the science behind the products so candidates with advanced science education will be considered as long as they are otherwise qualified. Candidates need expertise in developing models and valuations and the ability to do a detailed analysis. The strongest candidates are humble and open-minded with deep intellectual curiosity and critical thinking skills.
Candidates should have at least a Bachelor’s degree from a top college or university and have a track record of academic and professional success as demonstrated by high standardized test scores and GPA in the US and Canada or honors from non- North American schools. While an MBA or advanced science degree is not required, similar standards of excellence will apply to those degrees. Qualified candidates may forward a resume in Word along with academic metrics to our website. All inquiries will be treated confidentially.
Please note: You only need to submit your resume once. You will be considered for all open positions. Do not submit your resume to other jobs after submitting once.